Open AccessControversies about the use of serological markers in diagnosis of inflammatory bowel disease
Author(s) -
Quan Xie,
Hu Gan
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i2.279
Subject(s) - diamine oxidase , inflammatory bowel disease , serology , medicine , inflammatory bowel diseases , ulcerative colitis , disease , crohn's disease , gastroenterology , intestinal permeability , immunology , pathology , antibody , biology , biochemistry , enzyme
The serological markers are increasingly used in diagnosis of inflammatory bowel disease (IBD). D-lactate and diamine oxidase are new indicators that can be used to reveal the damage to intestinal mucosa and permeability alteration in IBD. Although the two biological markers seem more sensitive, recent clinical trials and animal experiments have shown controversies about the use of them in diagnosis of IBD. Therefore, these markers should be interpreted cautiously and further prospective studies are needed to establish their clinical role in diagnosis of IBD.